# Hematopoietic Stem Cell Microtransplantation for in AML

> **NCT02676856** · NA · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 40 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **PROCEDURE:** hematopoietic stem cell microtransplantation-long-term
- **PROCEDURE:** hematopoietic stem cell microtransplantation-short-term
- **DRUG:** Conditioning for CR group
- **DRUG:** Conditioning for Non-CR group

## Key facts

- **NCT ID:** NCT02676856
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2018-02
- **Final completion:** 2018-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-12-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02676856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02676856, "Hematopoietic Stem Cell Microtransplantation for in AML". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02676856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*